Naki Health
Naki Health46About
What does Naki Health do?
Naki Health pioneers precision medicine in mental health by providing a bioinformatics platform that helps patients and clinicians find the right treatment the first time. For patients, this means effective and personalized care, while for clinicians, it offers the best way to treat mental health disorders effectively and without delay by avoiding trial and error. The company's core offering addresses the difficulties in diagnosis and treatment for psychiatric disorders by revealing ideal treatm…
What is Naki Health's revenue?
StartupHub estimates Naki Health's annual revenue at $1.1M (range $635K to $2.8M, 69% confidence), based on comparable companies in the sector.
Where is Naki Health headquartered?
Naki Health is headquartered in New York, United States.
When was Naki Health founded?
Naki Health was founded in 2021.
What industry does Naki Health operate in?
Naki Health operates in Healthcare, Life Sciences, Biotech, Pathology, Blood, HealthTech.
How many employees does Naki Health have?
Naki Health has approximately 6 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Biotalent is a platform that streamlines biotech hiring by connecting qualified candidates with job opportunities and providing hiring teams with tools for efficient candidate review.
AI-powered platform accelerating biological research and drug discovery.
A healthcare and life sciences consulting firm leveraging AI and data analytics for strategic solutions.
Empowering Life Science Entrepreneurs for Innovative Healthcare Solutions.
An entrant is a company tagged Life Sciences whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.